Is Legend BiotechCorp Stock a Good Investment?
Legend BiotechCorp Investment Advice | LEGN |
- Examine Legend BiotechCorp's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Legend BiotechCorp's leadership team and their track record. Good management can help Legend BiotechCorp navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Legend BiotechCorp's business and its evolving consumer preferences.
- Compare Legend BiotechCorp's performance and market position to its competitors. Analyze how Legend BiotechCorp is positioned in terms of product offerings, innovation, and market share.
- Check if Legend BiotechCorp pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Legend BiotechCorp's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Legend BiotechCorp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Legend BiotechCorp is a good investment.
Sell | Buy |
Examine Legend BiotechCorp Stock
Researching Legend BiotechCorp's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 41.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.16. Legend BiotechCorp had not issued any dividends in recent years.
To determine if Legend BiotechCorp is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Legend BiotechCorp's research are outlined below:
| Legend BiotechCorp generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 117 M. Net Loss for the year was (445.72 M) with loss before overhead, payroll, taxes, and interest of (284.01 M). | |
| Legend BiotechCorp currently holds about 791.26 M in cash with (200.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11. | |
| Latest headline from news.google.com: Sum Up The Pieces FPX Could Be Worth 103 - Nasdaq |
Legend BiotechCorp Quarterly Cost of Revenue |
|
Legend BiotechCorp uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Legend BiotechCorp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Legend BiotechCorp's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 15th of August 2023 Upcoming Quarterly Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 31st of March 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Legend BiotechCorp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Legend BiotechCorp's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-05-18 | 2021-03-31 | -0.35 | -0.3 | 0.05 | 14 | ||
2022-12-14 | 2022-09-30 | -0.31 | -0.37 | -0.06 | 19 | ||
2021-03-18 | 2020-12-31 | -0.28 | -0.22 | 0.06 | 21 | ||
2021-11-16 | 2021-09-30 | -0.35 | -0.43 | -0.08 | 22 | ||
2023-05-18 | 2023-03-31 | -0.78 | -0.68 | 0.1 | 12 | ||
2022-03-18 | 2021-12-31 | -0.41 | -0.3 | 0.11 | 26 | ||
2020-11-16 | 2020-09-30 | -0.31 | -0.5 | -0.19 | 61 | ||
2023-02-17 | 2022-12-31 | -0.42 | -0.62 | -0.2 | 47 |
Legend BiotechCorp's SEC filings
Before you invest in Legend BiotechCorp, make sure you check Legend BiotechCorp'srecent SEC filings. These artifacts are important regulatory documents required of all public companies to provide to potential investors. Legend BiotechCorp prospectus issued under the guidelines of the SEC is a legal declaration of facts and statements to ensure that Legend BiotechCorp investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Legend BiotechCorp's specific information freely available to individual and institutional investors to make a timely investment decision.
| 25th of September 2023 Other Events | View | |
| 10th of May 2023 Unclassified Corporate Event | View |
Legend BiotechCorp Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Legend target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Legend BiotechCorp's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| Buy |
Most Legend analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Legend stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Legend BiotechCorp, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationLegend BiotechCorp Target Price Projection
Legend BiotechCorp's current and average target prices are 64.90 and 83.20, respectively. The current price of Legend BiotechCorp is the price at which Legend BiotechCorp is currently trading. On the other hand, Legend BiotechCorp's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Legend BiotechCorp Market Quote on 2nd of October 2023
Target Price
Analyst Consensus On Legend BiotechCorp Target Price
Legend BiotechCorp Analyst Ratings
Legend BiotechCorp's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Legend BiotechCorp stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Legend BiotechCorp's financials, market performance, and future outlook by experienced professionals. Legend BiotechCorp's historical ratings below, therefore, can serve as a valuable tool for investors.Know Legend BiotechCorp's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Legend BiotechCorp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Legend BiotechCorp backward and forwards among themselves. Legend BiotechCorp's institutional investor refers to the entity that pools money to purchase Legend BiotechCorp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Last Transaction | Type | Shares | Value | Fmr Llc | 2023-06-30 | Common Shares | 17 M | 1.2 B | Price T Rowe Associates Inc | 2023-06-30 | Common Shares | 9 M | 623.4 M | Hhlr Advisors Ltd | 2023-06-30 | Common Shares | 6.4 M | 444.3 M | Ra Capital Management Lp | 2023-06-30 | Common Shares | 6.3 M | 432.5 M | Blackrock Inc | 2023-06-30 | Common Shares | 4.7 M | 327.5 M | Capital World Investors | 2023-06-30 | Common Shares | 2.4 M | 164.8 M | Federated Hermes Inc | 2023-06-30 | Common Shares | 1.9 M | 134 M | Polar Capital Holdings Plc | 2023-06-30 | Common Shares | 1.9 M | 129.2 M | Capital International Investors | 2023-06-30 | Common Shares | 1.9 M | 128.5 M | Janus Henderson Group Plc | 2023-06-30 | Common Shares | 1.8 M | 125.2 M | Paradigm Biocapital Advisors Lp | 2023-06-30 | Common Shares | 1.8 M | 124.6 M |
Legend BiotechCorp's market capitalization trends
The company currently falls under 'Large-Cap' category with a current market capitalization of 13.05 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Legend BiotechCorp's market, we take the total number of its shares issued and multiply it by Legend BiotechCorp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
Legend BiotechCorp's profitablity analysis
Legend BiotechCorp's profitability indicators refer to fundamental financial ratios that showcase Legend BiotechCorp's ability to generate income relative to its revenue or operating costs. If, let's say, Legend BiotechCorp is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Legend BiotechCorp's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Legend BiotechCorp's profitability requires more research than a typical breakdown of Legend BiotechCorp's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for 2023 | ||
| Return on Average Assets | (0.36) | (0.39) | |
| Return on Average Equity | (0.59) | (0.64) | |
| Return on Invested Capital | (1.38) | (1.49) | |
| Return on Sales | (3.72) | (4.01) |
Determining Legend BiotechCorp's profitability involves analyzing its financial statements and using various financial metrics to determine if Legend BiotechCorp is a good buy. For example, gross profit margin measures Legend BiotechCorp's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Legend BiotechCorp's profitability and make more informed investment decisions.
The data published in Legend BiotechCorp's official financial statements usually reflect Legend BiotechCorp's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Legend BiotechCorp. For example, before you start analyzing numbers published by Legend accountants, it's critical to develop an understanding of what Legend BiotechCorp's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Legend BiotechCorp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Legend BiotechCorp's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Legend BiotechCorp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Legend BiotechCorp. Please utilize our Beneish M Score to check the likelihood of Legend BiotechCorp's management manipulating its earnings.
Evaluate Legend BiotechCorp's management efficiency
Legend BiotechCorp has return on total asset (ROA) of (0.2124) % which means that it has lost $0.2124 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5403) %, meaning that it created substantial loss on money invested by shareholders. Legend BiotechCorp's management efficiency ratios could be used to measure how well Legend BiotechCorp manages its routine affairs as well as how well it operates its assets and liabilities. As of 2nd of October 2023, Return on Average Assets is likely to drop to -0.39. In addition to that, Return on Average Equity is likely to drop to -0.64. As of 2nd of October 2023, Asset Turnover is likely to grow to 0.10, while Total Assets are likely to drop about 1.2 B.| Last Reported | Projected for 2023 | ||
| Book Value per Share | 4.68 | 4.09 | |
| Enterprise Value over EBIT | (16.00) | (17.26) | |
| Enterprise Value over EBITDA | (17.22) | (18.58) | |
| Price to Book Value | 10.35 | 9.96 | |
| Tangible Assets Book Value per Share | 8.35 | 8.04 | |
| Enterprise Value | 7.2 B | 7 B | |
| Tangible Asset Value | 1.3 B | 1.1 B |
The analysis of Legend BiotechCorp's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Legend BiotechCorp's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Legend Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Short Long Term Debt Total 284.5 M | Income Tax Expense 625 K | Interest Expense 10.8 M | Total Operating Expenses 509.7 M | Other Operating Expenses 575.1 M |
Basic technical analysis of Legend Stock
As of the 2nd of October, Legend BiotechCorp secures the Mean Deviation of 1.63, risk adjusted performance of (0.0048), and Standard Deviation of 2.21. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Legend BiotechCorp, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Legend BiotechCorp, which can be compared to its peers in the industry. Please verify Legend BiotechCorp coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and skewness to decide if Legend BiotechCorp is priced some-what accurately, providing market reflects its recent price of 64.9 per share. Given that Legend BiotechCorp has information ratio of (0.010667), we recommend you to check Legend BiotechCorp's last-minute market performance to make sure the company can sustain itself at a future point.Understand Legend BiotechCorp's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Legend BiotechCorp's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.0048) | |||
| Market Risk Adjusted Performance | (0.15) | |||
| Mean Deviation | 1.63 | |||
| Coefficient Of Variation | (5,121) | |||
| Standard Deviation | 2.21 | |||
| Variance | 4.87 | |||
| Information Ratio | (0.010667) | |||
| Jensen Alpha | (0.043446) | |||
| Total Risk Alpha | 0.0529 | |||
| Treynor Ratio | (0.16) | |||
| Maximum Drawdown | 12.9 | |||
| Value At Risk | (3.48) | |||
| Potential Upside | 3.22 | |||
| Skewness | 0.6946 | |||
| Kurtosis | 2.21 |
| Risk Adjusted Performance | (0.0048) | |||
| Market Risk Adjusted Performance | (0.15) | |||
| Mean Deviation | 1.63 | |||
| Coefficient Of Variation | (5,121) | |||
| Standard Deviation | 2.21 | |||
| Variance | 4.87 | |||
| Information Ratio | (0.010667) | |||
| Jensen Alpha | (0.043446) | |||
| Total Risk Alpha | 0.0529 | |||
| Treynor Ratio | (0.16) | |||
| Maximum Drawdown | 12.9 | |||
| Value At Risk | (3.48) | |||
| Potential Upside | 3.22 | |||
| Skewness | 0.6946 | |||
| Kurtosis | 2.21 |
Consider Legend BiotechCorp's intraday indicators
Legend BiotechCorp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Legend BiotechCorp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 21191.05 | |||
| Daily Balance Of Power | (0.69) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 65.51 | |||
| Day Typical Price | 65.3 | |||
| Price Action Indicator | (1.74) |
Legend Stock media impact
Far too much social signal, news, headlines, and media speculation about Legend BiotechCorp that are available to investors today. That information is available publicly through Legend media outlets and privately through word of mouth or via Legend internal channels. However, regardless of the origin, that massive amount of Legend data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Legend BiotechCorp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Legend BiotechCorp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Legend BiotechCorp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Legend BiotechCorp alpha.
Legend BiotechCorp Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Legend BiotechCorp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Legend BiotechCorp Maximum Pain Price across 2023-10-20 Option Contracts
Legend BiotechCorp's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Legend BiotechCorp close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Legend BiotechCorp's options.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Legend BiotechCorp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Legend BiotechCorp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend BiotechCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Legend Stock analysis
When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Directory Find actively traded corporate debentures issued by US companies | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.16) | Revenue Per Share 0.986 | Quarterly Revenue Growth 5.126 | Return On Assets (0.21) | Return On Equity (0.54) |
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Legend BiotechCorp's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.